iAnthus Capital HoldingsFRA:2IA PS Ratio is 0.03 as of Jul. 05, 2026, which is 93% below its 10-year median of 0.43. The stock has 4 warning signs investors should review. Among 949 Drug Manufacturers companies, iAnthus Capital Holdings ranks better than 97.05% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, iAnthus Capital Holdings's share price is €0.0005.
iAnthus Capital Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was €0.02. Hence, iAnthus Capital Holdings's PS Ratio for today is 0.03.
The historical rank and industry rank for iAnthus Capital Holdings's PS Ratio or its related term are showing as below:
FRA:2IA'
s PS Ratio Range Over the Past 10 Years
Min: 0.05 Med: 0.43 Max: 1235
Current: 0.18
During the past 11 years, iAnthus Capital Holdings's highest PS Ratio was 1235.00. The lowest was 0.05. And the median was 0.43.
FRA:2IA's PS Ratio is ranked better than 97.05% of 949
companies
in the Drug Manufacturers industry
Industry Median: 2.31
vs FRA:2IA: 0.18
During the past 11 years, iAnthus Capital Holdings's highest 3-Year average Revenue per Share Growth Rate was 176.00% per year. The lowest was -71.00% per year. And the median was -23.10% per year.
Back to Basics: PS Ratio
iAnthus Capital Holdings (FRA:2IA) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, iAnthus Capital Holdings's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
iAnthus Capital Holdings PS Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, iAnthus Capital Holdings's PS Ratio distribution charts can be found below:
* The bar in red indicates where iAnthus Capital Holdings's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
iAnthus Capital Holdings's Share Price of today is €0.0005. iAnthus Capital Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.02.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
iAnthus Capital Holdings (FRA:2IA) has a PS Ratio of 0.03 as of Jul. 05, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on iAnthus Capital Holdings and its competitors. This is 93% below median its historical median of 0.43. Over the past decade, iAnthus Capital Holdings' PS Ratio has ranged from 0.05 to 1,235.00. According to the industry distribution chart, iAnthus Capital Holdings ranks #28 out of 949 companies in the Drug Manufacturers industry, placing it in the top 3%.
Is iAnthus Capital Holdings' PS Ratio too high?
iAnthus Capital Holdings' current PS Ratio of 0.03 is 93% below median its 10-year median of 0.43. Over the past 10 years, this metric has ranged from a low of 0.05 to a high of 1,235.00. The Drug Manufacturers industry median PS Ratio is 2.31. iAnthus Capital Holdings' value of 0.03 is 98.7% below this industry median. Based on the distribution chart, iAnthus Capital Holdings ranks #28 out of 949 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers.
How does iAnthus Capital Holdings' PS Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, iAnthus Capital Holdings ranks #28 out of 949 companies for PS Ratio. This places iAnthus Capital Holdings in the top 3% of its industry — outperforming the majority of peers. The industry median PS Ratio is 2.31. iAnthus Capital Holdings' value of 0.03 is 98.7% below this benchmark. Historically, iAnthus Capital Holdings' own PS Ratio has ranged from 0.05 to 1,235.00 over the past decade. While the company's 10-year median is 0.43 vs. the industry median of 2.31, iAnthus Capital Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Drug Manufacturers company?
The median PS Ratio among Drug Manufacturers companies is 2.31, based on 949 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. iAnthus Capital Holdings's current PS Ratio of 0.03 is 98.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on iAnthus Capital Holdings and its competitors. For the Drug Manufacturers industry, the median PS Ratio is 2.31 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. iAnthus Capital Holdings's current PS Ratio is 0.03, which is 93% below median its own 10-year median of 0.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is iAnthus Capital Holdings stock overvalued right now?
iAnthus Capital Holdings (FRA:2IA) has a current PS Ratio of 0.03. The current PS Ratio is 0.03, which is 93% below median its 10-year median of 0.43 and 98.7% below the Drug Manufacturers industry median of 2.31. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For iAnthus Capital Holdings (FRA:2IA), the current PS Ratio is 0.03 as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
iAnthus Capital Holdings Inc is a vertically-integrated, multi-state owner and operator of licensed cannabis cultivation, processing, and dispensary facilities and a developer, producer, and distributor of branded cannabis products in the United States. Its Cannabis product offerings include flower and trim, products containing cannabis flower and trim (such as packaged flower and pre-rolls), cannabis infused products (such as topical creams and edibles), and products containing cannabis extracts (such as vape cartridges, concentrates, live resins, wax products, oils, and tinctures). The company's reportable operating segments are the Eastern Region, which generates the maximum revenue, and the Western Region.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:2IA has been successfully added to your 